共 50 条
- [1] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - EXPANDED ROLE FOR COMMITTEE MEMBERS - GUIDELINES ON ANALGESICS [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (12): : 1619 - 1619
- [2] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING [J]. ARTHRITIS AND RHEUMATISM, 1982, 25 (09): : 1124 - 1125
- [3] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING [J]. ARTHRITIS AND RHEUMATISM, 1982, 25 (05): : 595 - 596
- [4] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING [J]. ARTHRITIS AND RHEUMATISM, 1983, 26 (10): : 1288 - 1289
- [6] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING [J]. ARTHRITIS AND RHEUMATISM, 1985, 28 (04): : 450 - 451
- [8] FDA ADVISORY-COMMITTEE RECOMMENDS EARLIER USE OF ZIDOVUDINE [J]. CLINICAL PHARMACY, 1990, 9 (04): : 248 - 248
- [10] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - THERAFECTIN - ROLE OF ARTHRITIS ADVISORY-COMMITTEE IN FDA REVIEW PROCESS - PERSONNEL CHANGES - ISSUES OF OVER-THE-COUNTER SWITCHING [J]. ARTHRITIS AND RHEUMATISM, 1994, 37 (09): : 1408 - 1409